e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Insights into paediatric bronchology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reversible Color Blindness due to Ethambutol in a Pediatric Patient with Pulmonary Tuberculosis
T. Sismanlar Eyuboglu (Ankara, Turkey), S. Yasar Durmus (Ankara, Turkey), S. Sahin Karamert (Ankara, Turkey), A. Kaman (Ankara, Turkey), T. Teke (Ankara, Turkey), F. Oz (Ankara, Turkey), G. Tanir (Ankara, Turkey)
Source:
International Congress 2019 – Insights into paediatric bronchology
Session:
Insights into paediatric bronchology
Session type:
Thematic Poster
Number:
1063
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Sismanlar Eyuboglu (Ankara, Turkey), S. Yasar Durmus (Ankara, Turkey), S. Sahin Karamert (Ankara, Turkey), A. Kaman (Ankara, Turkey), T. Teke (Ankara, Turkey), F. Oz (Ankara, Turkey), G. Tanir (Ankara, Turkey). Reversible Color Blindness due to Ethambutol in a Pediatric Patient with Pulmonary Tuberculosis. 1063
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
The Value of Voluntary Cough Sounds for Diagnosis of Pulmonary Disease
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018
Anatomical and Functional Repercussions of Sequelae of Pulmonary Tuberculosis: Cross-Sectional Observational Study
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
The Efficacy Of Outpatient Pulmonary Rehabilitation After Bilateral Lung Transplantation; Case Series
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018
Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT
Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2018
Psychiatric Complications in Patients Receiving Treatment for Multi-Drug Resistant Tuberculosis
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Impact of the Smoking on Pulmonary Tuberculosis Process Course
Source: Eur Respir J 2005; 26: Suppl. 49, 419s
Year: 2005
Choir in the Pulmonary Rehabilitation Program
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017
Evaluation of Pulmonary Complication in Patient with Valvular Heart Surgery: Clinical and Laboratory Significances
Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Year: 2018
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Clinical Risk Stratification of Pulmonary Embolism to Support the Development of a Pulmonary Embolism Response Team (PERT) at a Tertiary Referral Hospital.
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
Is Virtual Autonomous Physiotherapist Tele-rehabilitation Program in Chronic Obstructive Pulmonary Disease equal to Hospital-Based Pulmonary Rehabilitation?
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020
Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis?
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Clinical Features of Pulmonary Hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Risk Factors for Mortality in Patients with Idiopathic Pulmonary Fibrosis Followed at Intensive Care Unit due to Acute Respiratory Failure
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Year: 2019
Long-term Outcome of Pulmonary Resection for Nontuberculous Mycobacterial Pulmonary Disease
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017
Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept